iPath Pure Beta Softs ETN
GRWN
GRWN was delisted on the 3rd of April, 2018.
1 hedge funds and large institutions have $2K invested in iPath Pure Beta Softs ETN in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
60% less capital invested
Capital invested by funds: $5K → $2K (-$3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $2K | -$3.38K | -137 | -61% |
|
GRWN Hedge Fund Activity: Q2 2016 in Review
1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Softs ETN (GRWN) for Q2 2016, worth a combined $2K — down 60% from $5K a quarter earlier.
Fund positioning in GRWN was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $3.38K.
- 1 institutional investor held iPath Pure Beta Softs ETN (GRWN) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $2K of iPath Pure Beta Softs ETN stock for Q2 2016, down 60% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Softs ETN positions in Q2 2016 and 0 closed out.
- The largest iPath Pure Beta Softs ETN seller in Q2 2016 was UBS Group, an estimated $3.38K sold.
Based on aggregated 13F filings for Q2 2016.